SlideShare a Scribd company logo
1 of 98
Download to read offline
Overview
Introduction
 Inflammation is a protective response intended to
eliminate the initial cause of cell injury as well as
necrotic cells and tissues resulting from the original
insult.
 It sets into motion the events that eventually heal and
reconstitute the sites of injury.
Inflammation
 Definition
Inflammation (Latin, inflamatio, to set
on fire) is a localized protective response
elicited by injury or destruction of tissues,
which serves to destroy, dilute or wall off
(sequester) both the injurious agent and
the injured tissue.
(Dorland’s medical dictionary; 30th
ed)
Inflammation
 Definition
Inflammation is a complex reaction to
injurious agents such as microbes and
damaged, usually necrotic, cells that consists
of vascular responses, migration and activation
of leukocytes and systemic reactions.
(Robins and Cotran; 7th
ed.)
History
 Egyptian papyrus (3000 BC)
 Celsus (1st
century AD) – 4 cardinal signs of
inflammation
 Virchow – fifth clinical sign i.e. functio laesa
 John Hunter (1973)– inflammation is not a
disease but a non-specific response that has a
salutary effect on its host.
History
 Julius Cohnheim (1839-1884) – described
the process of inflammation
 Ellie Metchnikoff – Phagocytosis
 Sir Thomas Lewis – chemical substances,
such as histamine locally induced by injury,
mediate the vascular changes of
inflammation
Inflammation
 Inflammation is divided into two basic patterns:
Acute Inflammation : It is the immediate and early
response to injury, designed to deliver leukocytes to
the site of injury.
(Robbins 7th
ed.)
Also defined as inflammation usually of sudden
onset characterized by classical signs, with
predominance of vascular and exudative processes.
(Dorlands Dic.)
Inflammation
 Chronic Inflammation : It is considered to be
inflammation of prolonged duration (weeks to
months to years) in which active inflammation,
tissue injury and healing proceed simultaneously.
(Robbins 7th
ed.)
 Inflammation of slow progress and marked chiefly
by the formation of new connective tissue.
(Dorlands Dic.)
Inflammation
 The inflammatory
response has many
players
 These include:
 Circulating cells
 Neutrophils
 Eosinophils and
Basophils
 Lymphocytes and
Monocytes
 Platelets
Inflammation
 Circulating Proteins :
 Clotting Factors
 Kininogens
 Complement
components
 Vascular wall cells :
 Endothelial cells in
direct contact with
blood
 Smooth muscle cells
that impart tone to
vessels
Inflammation
 Connective tissue cells
 Mast cells
 Macrophages
 Lymphocytes
 Fibroblast
 Extra cellular Matrix :
 Fibrous Structural
Proteins (e.g. Collagen &
Elastin)
 Gel forming
proteoglycans
 Adhesive glycoprotein
(e.g. Fibronectin)
Acute Inflammation
STIMULI FOR ACUTE INFLAMMATION
Infections (bacterial, viral, parasitic) and microbial toxins
 Trauma (blunt and penetrating)
 Physical and chemical agents (thermal injury, e.g., burns or
frostbite; irradiation; some environmental chemicals)
Tissue necrosis (from any cause)
Foreign bodies (splinters, dirt, sutures)
Immune reactions (also called hypersensitivity reactions)
Acute Inflammation
 Lewis experiment. Lewis induced the changes in
the skin of inner aspect of forearm by firm stroking
with the blunt point eliciting the triple response
Red line appears in a few seconds due to local
vasodilation.
Flare is the bright reddish appearance also due
to vasodilation of the adjacent arterioles.
Wheal is the swelling or edema due to
transudation of fluid into extravascular space.
Acute Inflammation
Red line – direct
vasodilating effect of
histamine
Flare – indirect vasodilating effect
of histamine by stimulating axon
reflex
Wheal – Histamine induced
increased permeability
Acute Inflammation
 Classical signs of inflammation (Celsus)
1. Heat (Calor)
2. Redness (Rubor)
3. Swelling (Tumor)
4. Pain (Dolor)
5. Loss of function (Functio laesa) (Virchow)
Acute Inflammation
 Acute inflammation has two main components:
Vascular Changes : Alteration in the vessel caliber
resulting in increased blood flow (vasodilation) and
structural changes that permits plasma proteins to
leave circulation (increased vascular permeability).
Cellular Events : Emigration of leukocytes from the
microcirculation and accumulation in the focus of
injury (cell recruitment and activation).
Vascular Changes
Vascular Changes
Starling’s Law:
Movement of fluid in and out of arterioles, capillaries and
venules is regulated by the balance between
1.Intravascular hydrostatic pressure – tends to force fluid
out of vessels
2.Osmotic pressure of the plasma proteins – tends to retain
fluid within the vessels
Vascular Changes
Transudate Vs Exudate
Transudate Exudate
Filtrate of blood plasma without
changes in endothelial
permeability
Oedema of inflamed tissue with
increased vascular permeability
Non-Inflammatory Oedema Inflammatory Oedema
Protein < 1g/dl Protein -- High 2.5-3.5 g/dl
Glucose – same as plasma Glucose – Low (<60 mg/dl)
Specific Gravity < 1.015 Specific Gravity > 1.018
pH > 7.3 pH < 7.3
Few Cells, mainly mesothelial
cells and cellular debris
Inflammatory as well as
parenchymal cells
eg. Oedema in congestive
cardiac failure Purulent exudate such as pus
Increased vascular permeability
Endothelial cell contraction leads to intercellular
gaps in venules.
Increased vascular permeability
Endothelial cell retraction :
 Reversible mechanism
 Induced by cytokine mediators (TNF & IL-1)
 Cause structural reorganization
 Cells retract
 Takes 4 to 6 hrs to develop and persists for 24hrs
or more
Increased vascular permeability
 Direct endothelial injury :
 Seen in severe injuries (burns, infections etc.)
 Leakage begins immediately after surgery and persists for
several hours. (immediate sustained response)
Increased vascular permeability
 Leukocyte dependent endothelial injury :
 Leukocytes may accumulate during inflammatory response.
 These leukocytes may release toxic oxygen species and
proteolytic enzymes causing injury.
Increased vascular permeability
 Leakage from new blood vessels :
Cellular Events
Cellular Events
Transendothelial Migration
 E-selectins are expressed at low levels or are not present at
all on normal cells. They are upregulated after stimulation by
specific mediators. eg.IL-1 and TNF.
 P-selectins are found intracellularly in Weibel-Palade bodies,
which once stimulated by mediators such as histamine are
distributed over the cell surface.
 L-selectins interact with carbohydrate molecules known as
vascular addresins (eg.sialomucin) on the luminal surface of
endothelial cells. This brief interaction manifests itself as
rolling of the leukocyte along the luminal surface of
endothelium.
Transendothelial Migration
Chemotaxis and Activation
 After extravasating from the blood, leukocytes
migrate toward sites of injury along a chemical
gradient in a process called chemotaxis.
 Both exogenous and endogenous substances can
be chemotactic for leukocytes.
 Soluble bacterial products : N-formylmethionine termini.
 Components of complement system : C5a
 Products of lipoxygenase pathway : leukotriene B4
 Cytokines : IL-1, IL-8
Chemotaxis and Activation
Biochemical Events In Leukocyte Activation
Phagocytosis and Degranulation
 Phagocytosis and the elaboration of degradative
enzyme are two major benefits of having recruited
leukocytes at the site of inflammation.
 Phagocytosis consists of three distinct but
interrelated steps:
 Recognition and attachment of the particle to the
ingesting leukocyte.
 Engulfment with subsequent formation of a
phagocytic vacuole
 Killing and degradation of the ingested material.
Phagocytosis and Degranulation
Phagocytosis and Degranulation
Phagocytosis and Degranulation
 2O2 +NADPH NADPH oxidase 2O2
-
+ NADP+
+ H+
 Superoxide is then converted by spontaneous
dismutation to hydrogen peroxide.
 O2
-
+ 2H+
H2O2
Cl-
 H2O2 Myeloperoxidase HOCl + H2O
Chemical Mediators Of
Inflammation
Vasoactive Amines
 Histamine – widely distributed in mast cells; also
present in circulating basophils and platelets.
 Preformed histamine is stored in mast cell granules and
released in response to a variety of stimuli :
 Physical injury
 Immune reactions involving binding of IgE antibodies to Fc
receptors on mast cells.
 Anaphylatoxins; C3a and C5a
 Leukocyte derived histamine releasing proteins.
 Neuropeptides
 Certain cytokines (IL-1; IL-8)
Vasoactive Amines
 Histamine causes arteriolar dilatation and is the
principal mediator of immediate phase of
increased vascular permeability.
 Soon after its release it is inactivated by
histaminase.
 Serotonin is also a preformed vasoactive mediator
with effects similar to those of histamine.
 Found in platelets and released during platelet
aggregation.
Neuropeptides
 Like vasoactive amines neuropeptides can initiate
inflammatory responses
 Nerve fibers that secrete neuropeptides are
prominent in lungs and GIT
 They are small proteins, such as substance P, that
transmit pain signals, regulate vascular tone and
modulate vascular permeability.
Plasma Proteases
 Many effects of inflammation are mediated by
three interrelated plasma derived factors :
 The Kinins all linked by initial
activation of
 The clotting system Hageman Factor( factor XII)
 The complement system
 Hageman factor is a protein synthesized by liver
that circulates in an inactive form until it
encounters collagen, basement membrane or
activated platelets.
Plasma Proteases
Complement system
Arachidonic acid metabolites
Platelet-Activating Factor
(PAF)
 Platelets, basophils, mast cells, neutrophils,
monocytes/macrophages and endothelial cells
 Vasoconstriction and bronchoconstriction
 Increased leucocyte adhesion to endothelium
 Chemotaxis, degranulation and oxidative burst
Cytokines
Nitric Oxide
Summary
References
 Robbins & Cotran. Pathologic basis of
disease; 7th
ed.
 Dorland’s medical dictionary; 30th
ed
 Harsh Mohan. Essential Pathology for Dental
Students.; 3rd
ed.
 Henry Trowbridge. Inflammation A review of
the process; 4th
ed.
Contents
 Fate of Acute Inflammation
 Morphologic patterns of Acute
Inflammation
 Chronic Inflammation
 SIRS & Sepsis
 Anti-Inflammatory agents
Fate of Acute Inflammation
Fate of Acute Inflammation
Abscess
A localized collection of pus (suppurative inflammation)
appearing in an acute or chronic infection, and associated
with tissue destruction, and swelling.
Pathogenesis: the necrotic tissue is surrounded by
pyogenic membrane, which is formed by fibrin and help in
localize the infection.
Abscess
Fate of Acute Inflammation
Abscess
Pathogenesis: the necrotic tissue is surrounded by
pyogenic membrane, which is formed by fibrin and help in
localize the infection.
Morphologic Patterns
Serous Inflammation
Inflammation of serous membrane
characterized by clear fluid in serous cavity
(pleural, peritoneal pericardial & synovial
cavities)
E.g. skin Blisters caused by Burns OR viral
infection
Morphologic Patterns
Morphologic Patterns
Fibrinous Inflammation
Severe injury with excessive deposition of Fibrin in serous
cavity
Exudate and Fluid is removed by lymphatic
Fibrinous exudate may be degraded by Fibrinolysis and
removed by macrophage resulting in Resolution.
Incomplete Removal of fibrin resulting in organization and
scarring with
Fibrous Adhesion of pleura OR pericardium.
Morphologic Patterns
Morphologic Patterns
Suppuration (purulent ) Inflammation
Large amount of Purulent exudates (pus) caused by
pyogenic Bacteria staph aureus and Streptococcus
pyogenes
E.g Boil = Furuncle = Abscess of Hair follicles .
Morphologic Patterns
Pseudomembraneous Inflammation
Very severe ulcerative inflammation of mucous membranes
Extensive Necrosis of surface epithelium
Severe acute Inflammation of underlying tissue
Pseudo membrane, consisting of exudate, fibrin,
neutrophils RBC, Bacteria and tissue debris
e.g. Diphtheria – Larynx . pseudomembraneous Colitis –
clostridium difficile
Morphologic Patterns
Pseudomembraneous Inflammation
Morphologic Patterns
Ulceration
An ulcer is a local defect, or excavation, of the surface of an
organ or tissue that is produced by the sloughing of
inflammatory necrotic tissue
Tissue necrosis and resultant inflammation exist on or near
a surface
e.g Gastric (peptic) ulcer
Chronic Inflammation
 Inflammation of prolonged duration (weeks or
months) in which active inflammation, tissue
destruction, and attempts at repair are proceeding
simultaneously
(Robbins 7th
ed.)
Chronic Inflammation
 Characterized by the following:
Chronic inflammatory cell infiltration lymphocytes,
plasma cells and macrophage
Tissue destruction by Inflammatory cells
Healing and Repair – involving New Blood Vesel
proliferation (Angiogenesis) and Fibrosis
Chronic Inflammation
Causes:
Persistent infections
Prolonged exposure to potentially toxic agents
 Silica  silicosis
 Toxic plasma lipid components  atherosclerosis
Autoimmunity
 Rheumatoid arthritis & LE
SIRS & Sepsis
 Systemic inflammatory response syndrome
(SIRS) is the clinical expression of the
action of complex intrinsic mediators of the
acute phase reaction.
 SIRS can be precipitated by events such
as infection, trauma, pancreatitis, and
surgery.
SIRS & Sepsis
SIRS & Sepsis
SIRS & Sepsis
 SIRS can compromise the function of various
organ systems resulting in Multiple Organ
Dysfunction Syndrome (MODS).
 Clinicians should learn to identify SIRS in their
patients at an early stage to determine the
underlying cause and treatment before the
SIRS progresses to a more severe form.
H1 Anti-histaminics
 Blocks histamine induced
bronchoconstriction, contraction of
intestinal and other smooth muscle
 Blocks triple response
 Suppresses manifestations of type I
hypersensitivity reactions
Corticosteroids
 Corticosteroids have an anti-inflammatory
action – Hench et al (1949)
 Average rate of cortisol secretion–15-20
mg/day
 Increase in response to stress
Corticosteroids
Corticosteroids
 Blocking the cleavage of arachidonic
acid  inhibit PG synthesis
 Stabilizes intracellular lysosome
membranes  decreased release of
mediators
Corticosteroids
 Decreases permeability of capillary
membranes & reduces amount of
plasma lost  reduced amount of
edema
 Decreased migration of WBC in
inflamed tissues  diminished
phagocytosis
Corticosteroids
 Primary effect – marked reduction in post-
operative edema
Therapeutic uses in OMFS:
 Removal of impacted teeth (Beirne &
Hollander)
 Multiple extractions with alveoloplasty
 Removal of tori
 Apicoectomy
Corticosteroids
 Orthognathic surgeries (Schaberg et al)
 Rhinoplasty (Koopmann)
 Management of TMJ disorders – intraarticular
injection of corticosteroid provides relief of
symptoms in acute osteoarthritis of TMJ
 No more than 3 injections at a minimal interval of
1-3 months are recommended
NSAIDs
 Peripheral acting analgesics
 Anti-inflammatory, antipyretic and anti-thrombotic
activity
 Most effective when administered preoperatively
or immediately postoperatively, before the effects
of anesthesia have been reversed completely
NSAIDs
 COX1 – present in platelets, stomach, kidney
(cytoprotective to GIT)
 COX 2– induced by cytokines & endotoxins at
the site of inflammation
 Newer NSAIDs safer because they are selective
for COX-2
NSAIDs
 NSAIDs – control postoperative pain
 Corticosteroids – control postoperative edema
 Combination provides best results, since
NSAIDs potentiate the anti-inflammatory action of
steroids
Steroids add to the analgesic effect of NSAID
Leukotriene antagonists
 Montelukast & Zafirlukast
 Antagonize cysLT1 mediated
bronchoconstriction, increased vascular
permeability and recruitment of eosinophils
 Indicated for prophylactic therapy of mild to
moderate asthma
Omalizumab
Omalizumab
 Does not bind to cell-bound IgE
 Therefore, does not trigger cell activation
by crosslinking of the IgE molecules on cell
membranes.
Omalizumab
Omalizumab
 Omalizumab reduces the allergen induced
late asthmatic response, airway
hyperresponsiveness and sputum
eosinophilia
 Reduces both asthma exacerbations and
corticosteroid requirement
 Agent may have a long-term anti-
inflammatory effect
Enzymes as anti-
inflammatory agents
 Cleave the antigenic surface protein of organisms
and digest their outer coat
 Reduce number and activity of receptors for
pathogen on host cells
 Detoxify blood and remove viruses from circulation
 Cause enhancement of immune cells to kill
bacteria, viruses, molds and fungi
Enzymes as anti-
inflammatory agents
 Break down immune complexes which block the
immune cells
 Accelerate the volume and fluidity of blood flow
 Bromelain modulate arachidonate pathway in
such a way that thromboxane production is
decreased with no effect on cyclooxygenase
Enzymes as anti-
inflammatory agents
 Powerful anti-oxidants and effectively combat the
harmful free radicals such as nitric oxide
 Block pro-inflammatory metabolites that
propagate the inflammation
 Possess anti-secretory and mucolytic qualities
and decrease acute phase reactions
Serratiopeptidase
 Proteolytic enzyme isolated from the
non-pathogenic enterobacteria Serratia
E15 found in silkworms
 Acts upon inflammation by thinning the
fluids in the body that collect around
injured areas and increases fluid
drainage
Serratiopeptidase
 Enhances tissue repair and reduces pain
 Ability to block the release of pain-inducing
amines from inflamed tissues
 Ability to dissolve dead and damaged
tissue
 Modifies cell-surface adhesion molecules
References
 Robbins & Cotran. Pathologic basis of disease; 7th
ed.
 Harsh Mohan. Essential Pathology for Dental Students.; 3rd
ed.
 Henry Trowbridge. Inflammation A review of the process; 4th
ed.
 Goodman & Gilman's The Pharmacologic Basis of Therapeutics -
11th Ed. (2006)
 Laskin DM, Giglio JA. The use of steroids and NSAID in Oral and
Maxillofacial Surgery. Oral and Maxillofacial Surgery Clinics of
North America. 2001 Feb; 13(1): 31-41.
References
 M. Soler et al. The anti-IgE antibody omalizumab reduces
exacerbations and steroid requirement in allergic asthmatics Eur
Respir J 2001; 18: 254–261
 G. Hanf et al. Omalizumab inhibits allergen challenge-induced nasal
response. Eur Respir J 2004; 23: 414–418.
 Shahid S . Role of Systemic Enzymes in Infections . WebmedCentral
COMPLEMENTARY MEDICINE 2012;3(1):WMC002504
 Chopra et al. A randomized, double-blind, placebo-controlled study
comparing the efficacy and safety of paracetamol, serratiopeptidase,
ibuprofen and betamethasone using the dental impaction pain
model. Int. J. Oral Maxillofac. Surg. 2009; 38: 350–355
Overview of Inflammation: Its Definition, History, Types, Mechanisms and Mediators

More Related Content

What's hot (20)

Inflammation and repair darpan
Inflammation and repair darpanInflammation and repair darpan
Inflammation and repair darpan
 
Acute And Chronic Inflammation
Acute And Chronic InflammationAcute And Chronic Inflammation
Acute And Chronic Inflammation
 
Patho inflammation
Patho inflammationPatho inflammation
Patho inflammation
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Morphology of-acute-inflammation
Morphology of-acute-inflammationMorphology of-acute-inflammation
Morphology of-acute-inflammation
 
chronic inflammation
chronic inflammationchronic inflammation
chronic inflammation
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Granulation tissue formation
Granulation tissue formationGranulation tissue formation
Granulation tissue formation
 
Acute inflammation(pathology)
Acute inflammation(pathology)Acute inflammation(pathology)
Acute inflammation(pathology)
 
Inflammation
InflammationInflammation
Inflammation
 
Inflammation, role and types.
Inflammation, role and types.Inflammation, role and types.
Inflammation, role and types.
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Healing and repair
Healing and repair Healing and repair
Healing and repair
 
Tissue repair
Tissue repairTissue repair
Tissue repair
 
Mechanisms of cell injury
Mechanisms of cell injuryMechanisms of cell injury
Mechanisms of cell injury
 
Inflammation
InflammationInflammation
Inflammation
 
Inflammation....
Inflammation....Inflammation....
Inflammation....
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
 
Necrosis,gangrene and apoptosis
Necrosis,gangrene and apoptosisNecrosis,gangrene and apoptosis
Necrosis,gangrene and apoptosis
 
Reversible cell injury I Pathology
Reversible cell injury I PathologyReversible cell injury I Pathology
Reversible cell injury I Pathology
 

Viewers also liked

General pathology lecture 5 inflammation & repair
General pathology lecture 5 inflammation & repairGeneral pathology lecture 5 inflammation & repair
General pathology lecture 5 inflammation & repairLheanne Tesoro
 
Cholecystitis & carcinoma of gallbladder
Cholecystitis & carcinoma of gallbladder Cholecystitis & carcinoma of gallbladder
Cholecystitis & carcinoma of gallbladder Baiti Basheer
 
Acute and Chronic Cholecystitis
Acute and Chronic CholecystitisAcute and Chronic Cholecystitis
Acute and Chronic CholecystitisSujith Jose
 
Lecture 50 chronic inflammation.ppt 4.11.11
Lecture 50  chronic inflammation.ppt 4.11.11Lecture 50  chronic inflammation.ppt 4.11.11
Lecture 50 chronic inflammation.ppt 4.11.11ayeayetun08
 
Acute and chronic inflammation 1 robbins
Acute and chronic inflammation 1  robbinsAcute and chronic inflammation 1  robbins
Acute and chronic inflammation 1 robbinssujiiss
 

Viewers also liked (9)

General pathology lecture 5 inflammation & repair
General pathology lecture 5 inflammation & repairGeneral pathology lecture 5 inflammation & repair
General pathology lecture 5 inflammation & repair
 
Inflammation
InflammationInflammation
Inflammation
 
Cholecystitis & carcinoma of gallbladder
Cholecystitis & carcinoma of gallbladder Cholecystitis & carcinoma of gallbladder
Cholecystitis & carcinoma of gallbladder
 
Acute and Chronic Cholecystitis
Acute and Chronic CholecystitisAcute and Chronic Cholecystitis
Acute and Chronic Cholecystitis
 
Pathology of Biliary Disorders.
Pathology of Biliary Disorders.Pathology of Biliary Disorders.
Pathology of Biliary Disorders.
 
Chronic cholecystitis
Chronic cholecystitisChronic cholecystitis
Chronic cholecystitis
 
Lecture 50 chronic inflammation.ppt 4.11.11
Lecture 50  chronic inflammation.ppt 4.11.11Lecture 50  chronic inflammation.ppt 4.11.11
Lecture 50 chronic inflammation.ppt 4.11.11
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Acute and chronic inflammation 1 robbins
Acute and chronic inflammation 1  robbinsAcute and chronic inflammation 1  robbins
Acute and chronic inflammation 1 robbins
 

Similar to Overview of Inflammation: Its Definition, History, Types, Mechanisms and Mediators

4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptxByamugishaJames
 
Inflammation, Tissue repair and fever
Inflammation, Tissue repair and feverInflammation, Tissue repair and fever
Inflammation, Tissue repair and feverMae Aguilar
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptxGALIBOIBRAHIM
 
Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxShikhaSachde
 
INFLAMMATION & WOUD HEALING..pptx
INFLAMMATION & WOUD HEALING..pptxINFLAMMATION & WOUD HEALING..pptx
INFLAMMATION & WOUD HEALING..pptxHappychifunda
 
INFLAMMATION — копия.pptx
INFLAMMATION — копия.pptxINFLAMMATION — копия.pptx
INFLAMMATION — копия.pptxSarvarshJanu
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and RepairNavid J. Ayon
 
inflammation 2- FINAL.powerpoint presentation
inflammation 2- FINAL.powerpoint  presentationinflammation 2- FINAL.powerpoint  presentation
inflammation 2- FINAL.powerpoint presentationdraryajyoti1
 
Lecture-inflamation_Engl_.ppt
Lecture-inflamation_Engl_.pptLecture-inflamation_Engl_.ppt
Lecture-inflamation_Engl_.pptBharath Doltade
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2hussamdr
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)hussamdr
 
pathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxpathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxDishaThakur53
 
Inflammation and repair rince
Inflammation and repair rinceInflammation and repair rince
Inflammation and repair rinceRince Mohammed
 

Similar to Overview of Inflammation: Its Definition, History, Types, Mechanisms and Mediators (20)

Inflammation
InflammationInflammation
Inflammation
 
Inflammation
InflammationInflammation
Inflammation
 
4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx
 
INFLAMMATION
INFLAMMATIONINFLAMMATION
INFLAMMATION
 
Inflammation, Tissue repair and fever
Inflammation, Tissue repair and feverInflammation, Tissue repair and fever
Inflammation, Tissue repair and fever
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx
 
Lect 3-inflammation
Lect 3-inflammationLect 3-inflammation
Lect 3-inflammation
 
Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptx
 
inflammaton.pptx
inflammaton.pptxinflammaton.pptx
inflammaton.pptx
 
INFLAMMATION & WOUD HEALING..pptx
INFLAMMATION & WOUD HEALING..pptxINFLAMMATION & WOUD HEALING..pptx
INFLAMMATION & WOUD HEALING..pptx
 
INFLAMMATION — копия.pptx
INFLAMMATION — копия.pptxINFLAMMATION — копия.pptx
INFLAMMATION — копия.pptx
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and Repair
 
inflammation 2- FINAL.powerpoint presentation
inflammation 2- FINAL.powerpoint  presentationinflammation 2- FINAL.powerpoint  presentation
inflammation 2- FINAL.powerpoint presentation
 
Lecture-inflamation_Engl_.ppt
Lecture-inflamation_Engl_.pptLecture-inflamation_Engl_.ppt
Lecture-inflamation_Engl_.ppt
 
Shock
ShockShock
Shock
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)
 
pathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxpathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
Inflammation and repair rince
Inflammation and repair rinceInflammation and repair rince
Inflammation and repair rince
 

Recently uploaded

LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 

Recently uploaded (20)

LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 

Overview of Inflammation: Its Definition, History, Types, Mechanisms and Mediators

  • 1.
  • 2.
  • 4. Introduction  Inflammation is a protective response intended to eliminate the initial cause of cell injury as well as necrotic cells and tissues resulting from the original insult.  It sets into motion the events that eventually heal and reconstitute the sites of injury.
  • 5. Inflammation  Definition Inflammation (Latin, inflamatio, to set on fire) is a localized protective response elicited by injury or destruction of tissues, which serves to destroy, dilute or wall off (sequester) both the injurious agent and the injured tissue. (Dorland’s medical dictionary; 30th ed)
  • 6. Inflammation  Definition Inflammation is a complex reaction to injurious agents such as microbes and damaged, usually necrotic, cells that consists of vascular responses, migration and activation of leukocytes and systemic reactions. (Robins and Cotran; 7th ed.)
  • 7. History  Egyptian papyrus (3000 BC)  Celsus (1st century AD) – 4 cardinal signs of inflammation  Virchow – fifth clinical sign i.e. functio laesa  John Hunter (1973)– inflammation is not a disease but a non-specific response that has a salutary effect on its host.
  • 8. History  Julius Cohnheim (1839-1884) – described the process of inflammation  Ellie Metchnikoff – Phagocytosis  Sir Thomas Lewis – chemical substances, such as histamine locally induced by injury, mediate the vascular changes of inflammation
  • 9. Inflammation  Inflammation is divided into two basic patterns: Acute Inflammation : It is the immediate and early response to injury, designed to deliver leukocytes to the site of injury. (Robbins 7th ed.) Also defined as inflammation usually of sudden onset characterized by classical signs, with predominance of vascular and exudative processes. (Dorlands Dic.)
  • 10. Inflammation  Chronic Inflammation : It is considered to be inflammation of prolonged duration (weeks to months to years) in which active inflammation, tissue injury and healing proceed simultaneously. (Robbins 7th ed.)  Inflammation of slow progress and marked chiefly by the formation of new connective tissue. (Dorlands Dic.)
  • 11. Inflammation  The inflammatory response has many players  These include:  Circulating cells  Neutrophils  Eosinophils and Basophils  Lymphocytes and Monocytes  Platelets
  • 12. Inflammation  Circulating Proteins :  Clotting Factors  Kininogens  Complement components  Vascular wall cells :  Endothelial cells in direct contact with blood  Smooth muscle cells that impart tone to vessels
  • 13. Inflammation  Connective tissue cells  Mast cells  Macrophages  Lymphocytes  Fibroblast  Extra cellular Matrix :  Fibrous Structural Proteins (e.g. Collagen & Elastin)  Gel forming proteoglycans  Adhesive glycoprotein (e.g. Fibronectin)
  • 14. Acute Inflammation STIMULI FOR ACUTE INFLAMMATION Infections (bacterial, viral, parasitic) and microbial toxins  Trauma (blunt and penetrating)  Physical and chemical agents (thermal injury, e.g., burns or frostbite; irradiation; some environmental chemicals) Tissue necrosis (from any cause) Foreign bodies (splinters, dirt, sutures) Immune reactions (also called hypersensitivity reactions)
  • 15. Acute Inflammation  Lewis experiment. Lewis induced the changes in the skin of inner aspect of forearm by firm stroking with the blunt point eliciting the triple response Red line appears in a few seconds due to local vasodilation. Flare is the bright reddish appearance also due to vasodilation of the adjacent arterioles. Wheal is the swelling or edema due to transudation of fluid into extravascular space.
  • 16. Acute Inflammation Red line – direct vasodilating effect of histamine Flare – indirect vasodilating effect of histamine by stimulating axon reflex Wheal – Histamine induced increased permeability
  • 17. Acute Inflammation  Classical signs of inflammation (Celsus) 1. Heat (Calor) 2. Redness (Rubor) 3. Swelling (Tumor) 4. Pain (Dolor) 5. Loss of function (Functio laesa) (Virchow)
  • 18. Acute Inflammation  Acute inflammation has two main components: Vascular Changes : Alteration in the vessel caliber resulting in increased blood flow (vasodilation) and structural changes that permits plasma proteins to leave circulation (increased vascular permeability). Cellular Events : Emigration of leukocytes from the microcirculation and accumulation in the focus of injury (cell recruitment and activation).
  • 20. Vascular Changes Starling’s Law: Movement of fluid in and out of arterioles, capillaries and venules is regulated by the balance between 1.Intravascular hydrostatic pressure – tends to force fluid out of vessels 2.Osmotic pressure of the plasma proteins – tends to retain fluid within the vessels
  • 22. Transudate Vs Exudate Transudate Exudate Filtrate of blood plasma without changes in endothelial permeability Oedema of inflamed tissue with increased vascular permeability Non-Inflammatory Oedema Inflammatory Oedema Protein < 1g/dl Protein -- High 2.5-3.5 g/dl Glucose – same as plasma Glucose – Low (<60 mg/dl) Specific Gravity < 1.015 Specific Gravity > 1.018 pH > 7.3 pH < 7.3 Few Cells, mainly mesothelial cells and cellular debris Inflammatory as well as parenchymal cells eg. Oedema in congestive cardiac failure Purulent exudate such as pus
  • 23. Increased vascular permeability Endothelial cell contraction leads to intercellular gaps in venules.
  • 24. Increased vascular permeability Endothelial cell retraction :  Reversible mechanism  Induced by cytokine mediators (TNF & IL-1)  Cause structural reorganization  Cells retract  Takes 4 to 6 hrs to develop and persists for 24hrs or more
  • 25. Increased vascular permeability  Direct endothelial injury :  Seen in severe injuries (burns, infections etc.)  Leakage begins immediately after surgery and persists for several hours. (immediate sustained response)
  • 26. Increased vascular permeability  Leukocyte dependent endothelial injury :  Leukocytes may accumulate during inflammatory response.  These leukocytes may release toxic oxygen species and proteolytic enzymes causing injury.
  • 27. Increased vascular permeability  Leakage from new blood vessels :
  • 30. Transendothelial Migration  E-selectins are expressed at low levels or are not present at all on normal cells. They are upregulated after stimulation by specific mediators. eg.IL-1 and TNF.  P-selectins are found intracellularly in Weibel-Palade bodies, which once stimulated by mediators such as histamine are distributed over the cell surface.  L-selectins interact with carbohydrate molecules known as vascular addresins (eg.sialomucin) on the luminal surface of endothelial cells. This brief interaction manifests itself as rolling of the leukocyte along the luminal surface of endothelium.
  • 32. Chemotaxis and Activation  After extravasating from the blood, leukocytes migrate toward sites of injury along a chemical gradient in a process called chemotaxis.  Both exogenous and endogenous substances can be chemotactic for leukocytes.  Soluble bacterial products : N-formylmethionine termini.  Components of complement system : C5a  Products of lipoxygenase pathway : leukotriene B4  Cytokines : IL-1, IL-8
  • 34. Biochemical Events In Leukocyte Activation
  • 35. Phagocytosis and Degranulation  Phagocytosis and the elaboration of degradative enzyme are two major benefits of having recruited leukocytes at the site of inflammation.  Phagocytosis consists of three distinct but interrelated steps:  Recognition and attachment of the particle to the ingesting leukocyte.  Engulfment with subsequent formation of a phagocytic vacuole  Killing and degradation of the ingested material.
  • 38. Phagocytosis and Degranulation  2O2 +NADPH NADPH oxidase 2O2 - + NADP+ + H+  Superoxide is then converted by spontaneous dismutation to hydrogen peroxide.  O2 - + 2H+ H2O2 Cl-  H2O2 Myeloperoxidase HOCl + H2O
  • 40. Vasoactive Amines  Histamine – widely distributed in mast cells; also present in circulating basophils and platelets.  Preformed histamine is stored in mast cell granules and released in response to a variety of stimuli :  Physical injury  Immune reactions involving binding of IgE antibodies to Fc receptors on mast cells.  Anaphylatoxins; C3a and C5a  Leukocyte derived histamine releasing proteins.  Neuropeptides  Certain cytokines (IL-1; IL-8)
  • 41. Vasoactive Amines  Histamine causes arteriolar dilatation and is the principal mediator of immediate phase of increased vascular permeability.  Soon after its release it is inactivated by histaminase.  Serotonin is also a preformed vasoactive mediator with effects similar to those of histamine.  Found in platelets and released during platelet aggregation.
  • 42. Neuropeptides  Like vasoactive amines neuropeptides can initiate inflammatory responses  Nerve fibers that secrete neuropeptides are prominent in lungs and GIT  They are small proteins, such as substance P, that transmit pain signals, regulate vascular tone and modulate vascular permeability.
  • 43. Plasma Proteases  Many effects of inflammation are mediated by three interrelated plasma derived factors :  The Kinins all linked by initial activation of  The clotting system Hageman Factor( factor XII)  The complement system  Hageman factor is a protein synthesized by liver that circulates in an inactive form until it encounters collagen, basement membrane or activated platelets.
  • 47. Platelet-Activating Factor (PAF)  Platelets, basophils, mast cells, neutrophils, monocytes/macrophages and endothelial cells  Vasoconstriction and bronchoconstriction  Increased leucocyte adhesion to endothelium  Chemotaxis, degranulation and oxidative burst
  • 51. References  Robbins & Cotran. Pathologic basis of disease; 7th ed.  Dorland’s medical dictionary; 30th ed  Harsh Mohan. Essential Pathology for Dental Students.; 3rd ed.  Henry Trowbridge. Inflammation A review of the process; 4th ed.
  • 52.
  • 53.
  • 54. Contents  Fate of Acute Inflammation  Morphologic patterns of Acute Inflammation  Chronic Inflammation  SIRS & Sepsis  Anti-Inflammatory agents
  • 55. Fate of Acute Inflammation
  • 56. Fate of Acute Inflammation Abscess A localized collection of pus (suppurative inflammation) appearing in an acute or chronic infection, and associated with tissue destruction, and swelling. Pathogenesis: the necrotic tissue is surrounded by pyogenic membrane, which is formed by fibrin and help in localize the infection.
  • 58. Fate of Acute Inflammation Abscess Pathogenesis: the necrotic tissue is surrounded by pyogenic membrane, which is formed by fibrin and help in localize the infection.
  • 59. Morphologic Patterns Serous Inflammation Inflammation of serous membrane characterized by clear fluid in serous cavity (pleural, peritoneal pericardial & synovial cavities) E.g. skin Blisters caused by Burns OR viral infection
  • 61. Morphologic Patterns Fibrinous Inflammation Severe injury with excessive deposition of Fibrin in serous cavity Exudate and Fluid is removed by lymphatic Fibrinous exudate may be degraded by Fibrinolysis and removed by macrophage resulting in Resolution. Incomplete Removal of fibrin resulting in organization and scarring with Fibrous Adhesion of pleura OR pericardium.
  • 63. Morphologic Patterns Suppuration (purulent ) Inflammation Large amount of Purulent exudates (pus) caused by pyogenic Bacteria staph aureus and Streptococcus pyogenes E.g Boil = Furuncle = Abscess of Hair follicles .
  • 64. Morphologic Patterns Pseudomembraneous Inflammation Very severe ulcerative inflammation of mucous membranes Extensive Necrosis of surface epithelium Severe acute Inflammation of underlying tissue Pseudo membrane, consisting of exudate, fibrin, neutrophils RBC, Bacteria and tissue debris e.g. Diphtheria – Larynx . pseudomembraneous Colitis – clostridium difficile
  • 66. Morphologic Patterns Ulceration An ulcer is a local defect, or excavation, of the surface of an organ or tissue that is produced by the sloughing of inflammatory necrotic tissue Tissue necrosis and resultant inflammation exist on or near a surface e.g Gastric (peptic) ulcer
  • 67. Chronic Inflammation  Inflammation of prolonged duration (weeks or months) in which active inflammation, tissue destruction, and attempts at repair are proceeding simultaneously (Robbins 7th ed.)
  • 68. Chronic Inflammation  Characterized by the following: Chronic inflammatory cell infiltration lymphocytes, plasma cells and macrophage Tissue destruction by Inflammatory cells Healing and Repair – involving New Blood Vesel proliferation (Angiogenesis) and Fibrosis
  • 69. Chronic Inflammation Causes: Persistent infections Prolonged exposure to potentially toxic agents  Silica  silicosis  Toxic plasma lipid components  atherosclerosis Autoimmunity  Rheumatoid arthritis & LE
  • 70. SIRS & Sepsis  Systemic inflammatory response syndrome (SIRS) is the clinical expression of the action of complex intrinsic mediators of the acute phase reaction.  SIRS can be precipitated by events such as infection, trauma, pancreatitis, and surgery.
  • 73. SIRS & Sepsis  SIRS can compromise the function of various organ systems resulting in Multiple Organ Dysfunction Syndrome (MODS).  Clinicians should learn to identify SIRS in their patients at an early stage to determine the underlying cause and treatment before the SIRS progresses to a more severe form.
  • 74.
  • 75. H1 Anti-histaminics  Blocks histamine induced bronchoconstriction, contraction of intestinal and other smooth muscle  Blocks triple response  Suppresses manifestations of type I hypersensitivity reactions
  • 76. Corticosteroids  Corticosteroids have an anti-inflammatory action – Hench et al (1949)  Average rate of cortisol secretion–15-20 mg/day  Increase in response to stress
  • 78.
  • 79. Corticosteroids  Blocking the cleavage of arachidonic acid  inhibit PG synthesis  Stabilizes intracellular lysosome membranes  decreased release of mediators
  • 80. Corticosteroids  Decreases permeability of capillary membranes & reduces amount of plasma lost  reduced amount of edema  Decreased migration of WBC in inflamed tissues  diminished phagocytosis
  • 81. Corticosteroids  Primary effect – marked reduction in post- operative edema Therapeutic uses in OMFS:  Removal of impacted teeth (Beirne & Hollander)  Multiple extractions with alveoloplasty  Removal of tori  Apicoectomy
  • 82. Corticosteroids  Orthognathic surgeries (Schaberg et al)  Rhinoplasty (Koopmann)  Management of TMJ disorders – intraarticular injection of corticosteroid provides relief of symptoms in acute osteoarthritis of TMJ  No more than 3 injections at a minimal interval of 1-3 months are recommended
  • 83. NSAIDs  Peripheral acting analgesics  Anti-inflammatory, antipyretic and anti-thrombotic activity  Most effective when administered preoperatively or immediately postoperatively, before the effects of anesthesia have been reversed completely
  • 84. NSAIDs  COX1 – present in platelets, stomach, kidney (cytoprotective to GIT)  COX 2– induced by cytokines & endotoxins at the site of inflammation  Newer NSAIDs safer because they are selective for COX-2
  • 85. NSAIDs  NSAIDs – control postoperative pain  Corticosteroids – control postoperative edema  Combination provides best results, since NSAIDs potentiate the anti-inflammatory action of steroids Steroids add to the analgesic effect of NSAID
  • 86. Leukotriene antagonists  Montelukast & Zafirlukast  Antagonize cysLT1 mediated bronchoconstriction, increased vascular permeability and recruitment of eosinophils  Indicated for prophylactic therapy of mild to moderate asthma
  • 88. Omalizumab  Does not bind to cell-bound IgE  Therefore, does not trigger cell activation by crosslinking of the IgE molecules on cell membranes.
  • 90. Omalizumab  Omalizumab reduces the allergen induced late asthmatic response, airway hyperresponsiveness and sputum eosinophilia  Reduces both asthma exacerbations and corticosteroid requirement  Agent may have a long-term anti- inflammatory effect
  • 91. Enzymes as anti- inflammatory agents  Cleave the antigenic surface protein of organisms and digest their outer coat  Reduce number and activity of receptors for pathogen on host cells  Detoxify blood and remove viruses from circulation  Cause enhancement of immune cells to kill bacteria, viruses, molds and fungi
  • 92. Enzymes as anti- inflammatory agents  Break down immune complexes which block the immune cells  Accelerate the volume and fluidity of blood flow  Bromelain modulate arachidonate pathway in such a way that thromboxane production is decreased with no effect on cyclooxygenase
  • 93. Enzymes as anti- inflammatory agents  Powerful anti-oxidants and effectively combat the harmful free radicals such as nitric oxide  Block pro-inflammatory metabolites that propagate the inflammation  Possess anti-secretory and mucolytic qualities and decrease acute phase reactions
  • 94. Serratiopeptidase  Proteolytic enzyme isolated from the non-pathogenic enterobacteria Serratia E15 found in silkworms  Acts upon inflammation by thinning the fluids in the body that collect around injured areas and increases fluid drainage
  • 95. Serratiopeptidase  Enhances tissue repair and reduces pain  Ability to block the release of pain-inducing amines from inflamed tissues  Ability to dissolve dead and damaged tissue  Modifies cell-surface adhesion molecules
  • 96. References  Robbins & Cotran. Pathologic basis of disease; 7th ed.  Harsh Mohan. Essential Pathology for Dental Students.; 3rd ed.  Henry Trowbridge. Inflammation A review of the process; 4th ed.  Goodman & Gilman's The Pharmacologic Basis of Therapeutics - 11th Ed. (2006)  Laskin DM, Giglio JA. The use of steroids and NSAID in Oral and Maxillofacial Surgery. Oral and Maxillofacial Surgery Clinics of North America. 2001 Feb; 13(1): 31-41.
  • 97. References  M. Soler et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Respir J 2001; 18: 254–261  G. Hanf et al. Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J 2004; 23: 414–418.  Shahid S . Role of Systemic Enzymes in Infections . WebmedCentral COMPLEMENTARY MEDICINE 2012;3(1):WMC002504  Chopra et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. Int. J. Oral Maxillofac. Surg. 2009; 38: 350–355